Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
McKesson
Queensland Health
Fish and Richardson
Cantor Fitzgerald
Accenture
Baxter
Medtronic
UBS
Federal Trade Commission

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018735

« Back to Dashboard
NDA 018735 describes ISOVUE-M 300, which is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. Additional details are available on the ISOVUE-M 300 profile page.

The generic ingredient in ISOVUE-M 300 is iopamidol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopamidol profile page.

Summary for NDA: 018735

Tradename:
7
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 018735

Mechanism of ActionX-Ray Contrast Activity

Suppliers and Packaging for NDA: 018735

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ISOVUE-128
iopamidol
INJECTABLE;INJECTION 018735 NDA BRACCO DIAGNOSTICS INC 0270-1314 0270-1314-15 10 BOTTLE in 1 BOX (0270-1314-15) > 200 mL in 1 BOTTLE
ISOVUE-128
iopamidol
INJECTABLE;INJECTION 018735 NDA BRACCO DIAGNOSTICS INC 0270-1314 0270-1314-30 10 VIAL, SINGLE-DOSE in 1 BOX (0270-1314-30) > 50 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength41%
Approval Date:Dec 31, 1985TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength61%
Approval Date:Dec 31, 1985TE:APRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength76%
Approval Date:Dec 31, 1985TE:APRLD:Yes

Expired Orange Book Patents for NDA: 018735

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco
ISOVUE-250
iopamidol
INJECTABLE;INJECTION018735-007Jul 6, 1992► Subscribe► Subscribe
Bracco
ISOVUE-M 200
iopamidol
INJECTABLE;INJECTION018735-001Dec 31, 1985► Subscribe► Subscribe
Bracco
ISOVUE-370
iopamidol
INJECTABLE;INJECTION018735-003Dec 31, 1985► Subscribe► Subscribe
Bracco
ISOVUE-M 300
iopamidol
INJECTABLE;INJECTION018735-004Dec 31, 1985► Subscribe► Subscribe
Bracco
ISOVUE-300
iopamidol
INJECTABLE;INJECTION018735-002Dec 31, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
US Department of Justice
Cipla
Johnson and Johnson
Boehringer Ingelheim
QuintilesIMS
AstraZeneca
Fuji
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot